PetIQ, Inc. (PETQ) |
30.98 -0.01 (-0.03%) 10-24 16:00 |
Open: | 30.99 |
High: | 31 |
Low: | 30.98 |
Volume: | 928,270 |
Market Cap: | 919(M) |
PE Ratio: | 83.73 |
Exchange: | NASDAQ Global Select |
Industry: | Drug Manufacturers - Specialty & Generic |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 36.28 |
Resistance 1: | 31.06 |
Pivot price: | 30.92 |
Support 1: | 30.82 |
Support 2: | 30.67 |
52w High: | 31.06 |
52w Low: | 15.09 |
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
EPS | 0.370 |
Book Value | 8.710 |
PEG Ratio | 0.68 |
Gross Profit | 0.000 |
Profit Margin (%) | 1.16 |
Operating Margin (%) | 8.63 |
Return on Assets (ttm) | 4.9 |
Return on Equity (ttm) | 5.5 |
Tue, 11 Feb 2025
PetIQ Names Camillo Pane as Chief Executive Officer - GlobeNewswire
Tue, 11 Feb 2025
PETQ Leadership Coup: Coty's Former CEO Takes Helm at PetIQ - Strategic Growth Move Signals Major Transformation - Stock Titan
Fri, 25 Oct 2024
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group - Stock Titan
Fri, 25 Oct 2024
PetIQ acquired by Bansk Group for $1.5 billion - Investing.com
Fri, 25 Oct 2024
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group - GlobeNewswire
Wed, 07 Aug 2024
PetIQ’s stock skyrockets after $1.5 billion sale to Bansk Group - MarketWatch
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |